Literature DB >> 21733265

African horse sickness in The Gambia: circulation of a live-attenuated vaccine-derived strain.

C A L Oura1, P A S Ivens, K Bachanek-Bankowska, A Bin-Tarif, D B Jallow, C Sailleau, S Maan, P C Mertens, C A Batten.   

Abstract

African horse sickness virus serotype 9 (AHSV-9) has been known for some time to be circulating amongst equids in West Africa without causing any clinical disease in indigenous horse populations. Whether this is due to local breeds of horses being resistant to disease or whether the AHSV-9 strains circulating are avirulent is currently unknown. This study shows that the majority (96%) of horses and donkeys sampled across The Gambia were seropositive for AHS, despite most being unvaccinated and having no previous history of showing clinical signs of AHS. Most young horses (<3 years) were seropositive with neutralizing antibodies specific to AHSV-9. Eight young equids (<3 years) were positive for AHSV-9 by serotype-specific RT-PCR and live AHSV-9 was isolated from two of these horses. Sequence analysis revealed the presence of an AHSV-9 strain showing 100% identity to Seg-2 of the AHSV-9 reference strain, indicating that the virus circulating in The Gambia was highly likely to have been derived from a live-attenuated AHSV-9 vaccine strain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21733265     DOI: 10.1017/S095026881100080X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  6 in total

1.  Seroprevalence and Risk Factors of African Horse Sickness in Three Agroecological Zones of Cameroon.

Authors:  Mohamed M F Ndebé; Mohamed M M Mouiche; Frédéric Moffo; Rodrigue N S Poueme; Julius Awah-Ndukum
Journal:  Vet Med Int       Date:  2022-05-14

2.  Entry-competent-replication-abortive African horse sickness virus strains elicit robust immunity in ponies against all serotypes.

Authors:  Edward Sullivan; Sylvie Lecollinet; Adeline Kerviel; Erika Hue; Stéphane Pronost; Cécile Beck; Marine Dumarest; Stephan Zientara; Polly Roy
Journal:  Vaccine       Date:  2021-05-03       Impact factor: 3.641

3.  Serotype specific primers and gel-based RT-PCR assays for 'typing' African horse sickness virus: identification of strains from Africa.

Authors:  Narender S Maan; Sushila Maan; Kyriaki Nomikou; Manjunatha N Belaganahalli; Katarzyna Bachanek-Bankowska; Peter P C Mertens
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

4.  Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus.

Authors:  Yuta Kanai; Piet A van Rijn; Mieke Maris-Veldhuis; Yuki Kaname; T N Athmaram; Polly Roy
Journal:  Vaccine       Date:  2014-07-18       Impact factor: 3.641

5.  Assembly of Replication-Incompetent African Horse Sickness Virus Particles: Rational Design of Vaccines for All Serotypes.

Authors:  Valeria Lulla; Aleksei Lulla; Kerstin Wernike; Andrea Aebischer; Martin Beer; Polly Roy
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

6.  Protective efficacy of multivalent replication-abortive vaccine strains in horses against African horse sickness virus challenge.

Authors:  Valeria Lulla; Andres Losada; Sylvie Lecollinet; Adeline Kerviel; Thomas Lilin; Corinne Sailleau; Cecile Beck; Stephan Zientara; Polly Roy
Journal:  Vaccine       Date:  2017-06-29       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.